Resposta para o Editor: Em referência à carta para Viscosuplementação - Rezende MU, Campos GC. Rev Bras Ortop 2012;47(2):160-164

Márcia Uchoa de Rezende

doi:10.1055/s-0041-1728705

Revista Brasileira de Ortopedia, Table of Contents

CC BY-NC-ND 4.0 · Rev Bras Ortop (Sao Paulo) 2021; 56(02): 272-273
DOI: 10.1055/s-0041-1728705

Carta ao Editor

Joelho

Response Letter to Editor: In Reference to Letter to Viscosuplementation - Rezende MU, Campos GC. Rev Bras Ortop 2012;47(2):160-164

Article in several languages: português | English

Márcia Uchoa de Rezende

¹Departamento de Ortopedia e Traumatologia, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (FMUSP), São Paulo, SP, Brasil

› Author Affiliations

Abstract

Full Text

References

Referências
1 Agerup B, Berg P, Akermark C. Non-animal stabilized hyaluronic acid: a new formulation for the treatment of osteoarthritis. BioDrugs 2005; 19 (01) 23-30 https://idp.springer.com/authorize/casa?redirect_uri=https://link.springer.com/article/10.2165/00063030-200519010-00003&casa_token=JSisFArN0aYAAAAA:Z2LMISt_iDFCWsyWOssI-tt3SPlOUxUGlCGP75DWNtJvqMVRtPYTRgtpzH0hbnin8Erj1zBghN-FCiOK5Q
2 Ågerup B. Polysaccharide gel composition. US Patent. Published online October 27, 1998 [accessed February 8, 2021]. Available from: https://patentimages.storage.googleapis.com/0a/88/88/ec49d4a8dcf930/US5827937.pdf
3 Lindqvist U, Tolmachev V, Kairemo K, Aström G, Jonsson E, Lundqvist H. Elimination of stabilised hyaluronan from the knee joint in healthy men. Clin Pharmacokinet 2002; 41 (08) 603-613
4 Ågren UM, Tammi RH, Tammi MI. Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture. Free Radic Biol Med 1997; 23 (07) 996-1001
5 Kemper F, Gebhardt U, Meng T, Murray C. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice. Curr Med Res Opin 2005; 21 (08) 1261-1269
6 Altman RD, Åkermark C, Beaulieu AD, Schnitzer T. Durolane International Study Group. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage 2004; 12 (08) 642-649
7 McGrath AF, McGrath AM, Jessop MA. et al. A comparison of intra-articular hyaluronic acid competitors in the treatment of mild to moderate knee osteoarthritis. J Arthritis 2013; 2 (01) 1-5
8 Ozturk C, Atamaz F, Hepguler S, Argin M, Arkun R. The safety and efficacy of intraarticular hyaluronan with/without corticosteroid in knee osteoarthritis: 1-year, single-blind, randomized study. Rheumatol Int 2006; 26 (04) 314-319
9 de Campos GC, Rezende MU, Pailo AF, Frucchi R, Camargo OP. Adding triamcinolone improves viscosupplementation: a randomized clinical trial. Clin Orthop Relat Res 2013; 471 (02) 613-620